Treatment of subclinical intraurethral human papilloma virus infection with interferon alfa-2b

Urology

Volumn 47, Issue 4, 1996, Pages 553-557

  Levine, Laurence A ^a,b   Elterman, Lev ^a   Rukstalis, Daniel B ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

ADULT; ARTICLE; BLOOD ANALYSIS; DISEASE CONTROL; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SELF REPORT; SEMEN ANALYSIS; SEXUALLY TRANSMITTED DISEASE; TREATMENT PLANNING; VIRUS INFECTION; WART VIRUS;

EID: 0029889630     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80494-4     Document Type: Article

References (29)

1. Becker TM, Stone KM, and Alexander ER: Genital human papilloma virus infection. A growing concern. Obstet Gynecol Clin North Am 14: 389-396, 1987.
2. Durst M, Gissmann L, Ikenberg H, and zur Haussen H: A papilloma virus DNA from a cervical carcinoma and its prevalence in cancer biopsy specimens from different geographic regions. Proc Natl Acad Sci USA 80: 3812-3815, 1983.
3. Lorincz AT, Temple GF, Kurman RJ, Jenson AB, and Lancaster WD: Oncogenic association of specific human papilloma virus types with cervical neoplasia. J Natl Cancer Inst 79: 671-677, 1987.
4. Singer A: A male factor in the etiology of cervical cancer? Oxford Med Sci Gaz 25: 18, 1973.
5. Kessler II: Venereal factors in human cervical cancer. Cancer 39: 1912-1919, 1977.
6. Zunzunegui MV, King MC, Coria CF, and Charlet J: Male influences on cervical cancer risk. Am J Epidemiol 123: 302-307, 1986.
7. Rosemberg SK, Reid R, Greenberg M, and Lorincz AT: Sexually transmitted papilloma viral infection in the male: II. The urethral reservoir. Urology 32: 47-49, 1988.
8. Wiener JS, Effert PJ, Humpphrey PA, Yu L, Liu ET, and Walther PJ: Prevalence of human papilloma virus types 16 and 18 in squamous-cell carcinoma of the penis: a retrospective analysis of primary and metastatic sections by differential polymerase chain reaction. Int J Cancer 50: 694-701, 1992.
9. Carpiniello VL, Zderic SA, Malloy TR, and Sedlacek T: Carbon dioxide laser therapy of subclinical condyloma found by magnified penile surface scanning. Urology 29: 608-610, 1987.
10. Mellinger BC: Sexually transmitted diseases: viral infections. Infect Urol 5: 163-169, 1992.
11. Koutsky LA, Galloway DA, and Holmes KK: Epidemiology of genital human papilloma virus infection. Epidemiol Rev 10: 122-163, 1988.
12. Cecchini S, Cipparrone I, Confortini M, Scuderi A, Meini L, and Piazzesi G: Urethral cytology of Cytobrush specimens. A new technique for detecting subclinical human papilloma virus infection in men. Acta Cytol 32: 314-317, 1988.
13. Friedman RM: Interferons: a Primer. New York, Academic Press, 1981, pp 3-11.
14. Agarwal C, Hembree JR, Rorke EA, and Eckert RL: Interferon and retinoic acid suppress the growth of human papilloma virus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papilloma virus transforming oncogenes. Cancer Res 54: 2108-2112, 1994.
15. 2 in cells stimulated from quiescence to growth. Nature 274: 798-800, 1978.
16. Salmon SE, Durie BG, Young L, Liu RM, Trown PW, and Stebbing N: Effects of cloned human leukocyte interferons in the human tumor stem cell assay. J Clin Oncol 1: 217-225, 1983.
17. Welander CE, Morgan TM, Homesley HD, Trotta PP, and Spiegel RJ: Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay. Int J Cancer 35: 721-729, 1985.
18. Herberman RB, Ortaldo JR, Mantovani A, Hobbs DS, Kung HF, and Pestka S: Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol 67: 160-167, 1982.
19. Friedman-Kien AE, Eron LJ, Conant M, Growdon W, Badiak H, Bradsteet PW, Fedorczyk D, Trout JR, and Plasse TF: Natural interferon alpha for treatment of condylomata acuminata. JAMA 259: 533-538, 1988.
20. Eron LJ, Judson F, Tucker S, Prawer S, Mills J, Murphy K, Hickey M, Rogers M, Flannigan S, Hien N, et al: Interferon therapy for condylomata acuminata. N Engl J Med 315: 1059-1064, 1986.
21. Vance JC, Bart BJ, Hansen RC, Reichman RC, McEwen C, Hatch KD, Berman B, and Tanner DJ: Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 122: 272-277, 1986.
22. Reichman RC, Oakes D, Bonnez W, Greisberger C, Tyring S, Miller L, Whitley R, Carveth H, Weidner M, Krueger G, et al: Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial. Ann Intern Med 108: 675-679, 1988.
23. Glashan RW: A randomized controlled study of intravesical a-2b-interferon in carcinoma in situ of the bladder. J Urol 144: 658-661, 1990.
24. Dretler SP, and Klein LA: The eradication of intraurethral condyloma acuminata with 5 per cent 5-fluorouracil cream. J Urol 113: 195-198, 1975.
25. Carpiniello VL, Schoenberg M, and Malloy TR: Long-term follow-up of subclinical human papilloma virus infection treated with the carbon dioxide laser and intraurethral 5-fluorouracil: a treatment protocol. J Urol 143: 726-728, 1990.
26. Gigax JH, and Robinson JR: The successful treatment of intraurethral condyloma acuminata with colchicine. J Urol 105: 809-811, 1971.
27. Halverstadt DB, and Parry WL: Thiotepa in the management of intraurethral condylomata accuminata. J Urol 101: 729-731, 1969.
28. Schneider A, Meinhardt G, De-Villiers EM, and Gissmann L: Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV-DNA hybridization studies. Diagn Cytopathol 3: 250-255, 1987.
29. Gupta JW, Gupta PK, Rosenshein N, and Shah KV: Detection of human papilloma virus in cervical smears. A comparison of in situ hybridization, immunocytochemistry and cytopathology. Acta Cytol 31: 387-396, 1987.